|
Characteristics
|
B
|
SE
|
Wald
|
HR
|
95%CI
|
P value
|
|---|
|
Lower
|
Upper
|
|---|
|
Univariate survival analyses
|
|
Age
|
0.212
|
0.162
|
1.724
|
1.237
|
0.901
|
1.698
|
0.189
|
|
Menopausal status
|
0.285
|
0.165
|
2.982
|
1.330
|
0.962
|
1.838
|
0.084
|
|
Histological grade
|
0.049
|
0.098
|
0.256
|
1.051
|
0.868
|
1.272
|
0.613
|
|
Clinical stage
|
0.870
|
0.179
|
23.608
|
2.386
|
1.680
|
3.389
|
0.000**
|
|
LN metastasis
|
0.451
|
0.164
|
7.521
|
1.570
|
1.137
|
2.166
|
0.006**
|
|
ER
|
0.241
|
0.164
|
2.164
|
1.273
|
0.923
|
1.755
|
0.141
|
|
PR
|
0.094
|
0.164
|
0.326
|
1.098
|
0.796
|
1.514
|
0.568
|
|
Her2
|
0.579
|
0.169
|
11.789
|
1.785
|
1.282
|
2.484
|
0.001**
|
|
Mortalin
|
0.550
|
0.171
|
10.343
|
1.732
|
1.239
|
2.422
|
0.001**
|
|
Multivariate survival analyses
|
|
Clinical stage
|
0.690
|
0.187
|
13.615
|
1.994
|
1.382
|
2.876
|
0.000**
|
|
LN metastasis
|
0.270
|
0.170
|
2.518
|
1.310
|
0.938
|
1.829
|
0.113
|
|
Her2
|
0.442
|
0.172
|
6.575
|
1.556
|
1.110
|
2.182
|
0.010*
|
|
Mortalin
|
0.427
|
0.175
|
5.940
|
1.533
|
1.087
|
2.162
|
0.015*
|
- * p < 0.05 and ** p < 0.01
